Hess Viviane
Medizinische Onkologie, Universitätsspital Basel, Petersgraben 4, Basel.
Ther Umsch. 2008 Apr;65(4):201-5. doi: 10.1024/0040-5930.65.4.201.
Adjuvant chemotherapy dramatically improves prognosis for early breast cancer. Large, international randomized studies with thousands of patients not only introduced new effective drugs, but also led towards more individualized treatment strategies based on a number of prognostic factors. The integration, however, of the growing amount of information from clinical trials into every-day decision-making becomes an increasingly difficult task. Adjuvant!Online is an open-access computer program (www.adjuvantonline.com). From the entries of patient information and tumour characteristics the program calculates a prognostic estimate of outcome in terms of relapse and survival with and without adjuvant chemotherapy. This article focuses on the advantages and pitfalls in using Adjuvant!Online for informed treatment decisions in early breast cancer.
辅助化疗显著改善早期乳腺癌的预后。涉及数千名患者的大型国际随机研究不仅引入了新的有效药物,还基于多种预后因素推动了更具个体化的治疗策略。然而,将来自临床试验的信息量不断增加的信息整合到日常决策中,正成为一项日益艰巨的任务。辅助治疗在线(Adjuvant!Online)是一个开放获取的计算机程序(www.adjuvantonline.com)。该程序根据患者信息和肿瘤特征的输入,计算出在接受和不接受辅助化疗情况下复发和生存方面的预后结局估计值。本文重点探讨使用辅助治疗在线(Adjuvant!Online)为早期乳腺癌做出明智治疗决策的优势和缺陷。